<DOC>
	<DOCNO>NCT01985061</DOCNO>
	<brief_summary>Albeit safety stem cell transplantation procedure greatly improve , refine intensity conditioning important issue explore , especially patient poor prognosis , goal maintain favorable safety profile improve disease control . This goal prospective trial ; aim prospectively evaluate prospective multicenter trial efficacy different conditioning regimens patient high-risk myeloid malignancy . The study phase II trial randomize patient prospective active control arm ( BX2 ) two experimental arm ( BX3 BX4 ) . A standard group keep clinical trial order avoid limitation induce comparison historical control context continuously improve practice . Each experimental arm conduct parallel accord standard phase II trial design . In addition , trial associate four ancillary study main clinical objective : 1/ prospective assessment quality life patient period 2 year 2/ analysis cost effectiveness procedure , assess period 2 year 3/ observational busulfan pharmacokinetic study 4/ busulfan pharmacogenomic study</brief_summary>
	<brief_title>Evaluation 3 Different Doses IV Busulfan</brief_title>
	<detailed_description />
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<criteria>1 . Patients poor prognosis myeloid malignancy : Myelodysplastic syndrome , Acute Myeloid Leukemia ( AML ) beyond Complete Response ( CR1 ) , CR1 AML poor risk cytogenetics 2 . Adult patient : age â‰¥ 55 year 65 &lt; 55 year eligible myeloablative condition regimen base Total Body Irradiation ( TBI ) double alkylating agent combination . 3 . Availability HLA identical sibling match unrelated donor ( 10/10 ) 4 . Affiliation social security 5 . Written Informed Consent 1 . History previous AlloHematological Stem Cell Transplantation ( HSCT ) 2 . HIV positivity 3 . Signs chronic active hepatitis B and/or C 4 . Evolutive psychiatric disease 5 . Concomitant neoplastic disease 6 . Pregnant lactate woman without contraception ( child bear potential woman ) 7 . Usual contraindication AlloHSCT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Myelodysplasic syndrome</keyword>
	<keyword>Acute Myeloid leukemia</keyword>
</DOC>